Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099552 · ClinicalTrials.gov registry record
Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia
A clinical trial, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 150
- Enrollment target
NCT02099552 is a clinical trial that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 150 participants.
The verdict
NCT02099552 has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The proposed natural history study will enroll male and female patients, ages 36 months and younger, who have a diagnosis of XLHED based on genetic testing and who have not received an investigational study drug. The study protocol will include collection of all relevant medical history and documentation of clinical outcomes using age-appropriate, minimally invasive technologies. Data will be collected both retrospectively, back to pregnancy assessments that may be available, and prospectively through age 5 yrs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02099552
The ClinicalTrials.gov registry entry for NCT02099552 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edimer Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02099552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02099552 about?
NCT02099552 is a clinical study titled "Natural History and Outcomes in X-Linked Hypohidrotic Ectodermal Dysplasia". The proposed natural history study will enroll male and female patients, ages 36 months and younger, who have a diagnosis of XLHED based on genetic testing and who have not received an investigational study drug. The study protocol will include collection of all relevant medical history and document...
What is the current status of trial NCT02099552?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-04. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT02099552?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.